MedPath

Cali Pharmaceuticals LLC

Ownership
Private
Employees
-
Market Cap
-
Website

CPL-01 in the Management of Postoperative Pain After Bunionectomy

Phase 3
Recruiting
Conditions
Bunion
Interventions
Drug: Local anesthetic injection of CPL-01
Drug: Placebo
Drug: Naropin, 0.5% Injectable Solution
First Posted Date
2023-04-26
Last Posted Date
2024-08-20
Lead Sponsor
Cali Pharmaceuticals LLC
Target Recruit Count
574
Registration Number
NCT05831449
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Todd Bertoch, Salt Lake City, Utah, United States

Herniorrhaphy for Postoperative Pain

Phase 3
Recruiting
Conditions
Hernia, Inguinal
Interventions
Drug: local anaesthetic injection
First Posted Date
2023-04-14
Last Posted Date
2024-08-20
Lead Sponsor
Cali Pharmaceuticals LLC
Target Recruit Count
504
Registration Number
NCT05813847
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Todd Bertoch, Salt Lake City, Utah, United States

Post-Operative Pain and Opioid Reduction Trial After Bunionectomy

Phase 2
Completed
Conditions
Hallux Valgus and Bunion
Interventions
Drug: Analgesic Non Narcotic
First Posted Date
2022-06-09
Last Posted Date
2023-01-11
Lead Sponsor
Cali Pharmaceuticals LLC
Target Recruit Count
73
Registration Number
NCT05411861
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arizona Research Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Jean Brown Research, Salt Lake City, Utah, United States

๐Ÿ‡บ๐Ÿ‡ธ

Trovare Clinical Research, Bakersfield, California, United States

A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

Phase 2
Completed
Conditions
Inguinal Herniorrhaphy
Interventions
First Posted Date
2021-10-18
Last Posted Date
2022-07-20
Lead Sponsor
Cali Pharmaceuticals LLC
Target Recruit Count
105
Registration Number
NCT05080959
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Anaheim Clinical Trials, Anaheim, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Shoals Medical Trials, Inc, Sheffield, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arizona Research Center, Phoenix, Arizona, United States

and more 2 locations

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

Phase 2
Completed
Conditions
Abdominoplasty
Interventions
Drug: Placebo
First Posted Date
2019-12-02
Last Posted Date
2022-09-21
Lead Sponsor
Cali Pharmaceuticals LLC
Target Recruit Count
20
Registration Number
NCT04182880
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Chesapeake Research Group, Pasadena, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath